Literature DB >> 20150546

Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study.

Chao-Chien Hu1, Jau-Der Ho, Herng-Ching Lin.   

Abstract

BACKGROUND AND
PURPOSE: Using a nationwide population-based data set from Taiwan, this study investigated the relationship between neovascular age-related macular degeneration (AMD) and the risk of stroke over a 5-year period.
METHOD: The study cohort comprised 209 patients who received treatment for AMD between 1999 and 2001. We randomly selected 1045 subjects matched with the study cohort in terms of age and gender for comparison. Cox proportional hazard regressions were performed to compare the 5-year stroke-free survival rate.
RESULTS: Among the sampled patients, 142 patients (11.3%) had strokes during the 5-year follow-up period, 38 (18.2% of the patients with AMD) from the study cohort and 104 (9.9% of patients in the comparison cohort) from the comparison cohort. After adjusting for the patient's age, gender, monthly income, level of urbanization, and the geographic region of the community in which the patient resided and comorbidities, the hazard ratio for stroke during the follow-up period was 2.01 (P=0.001) times greater for patients with AMD than for patients without AMD. The adjusted hazard ratio for stroke during the follow-up period was 2.21 (P=0.001) times higher for patients with AMD > or = 65 years old compared with the same age group in the comparison cohort. However, no significant difference was observed in the risk of stroke between patients with AMD <65 years of age and comparison patients in the same age group.
CONCLUSION: We conclude that neovascular AMD is associated with a higher risk of stroke for patients with AMD > or = 65 years old.

Entities:  

Mesh:

Year:  2010        PMID: 20150546     DOI: 10.1161/STROKEAHA.109.571000

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  Comorbidity profile of poliomyelitis survivors in a Chinese population: a population-based study.

Authors:  Jiunn-Horng Kang; Herng-Ching Lin
Journal:  J Neurol       Date:  2011-01-30       Impact factor: 4.849

2.  Age-related macular degeneration and long-term risk of stroke subtypes.

Authors:  M Kamran Ikram; Paul Mitchell; Ronald Klein; A Rickey Sharrett; David J Couper; Tien Y Wong
Journal:  Stroke       Date:  2012-04-24       Impact factor: 7.914

3.  Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Antonio B Fernandez; Tien Y Wong; Ronald Klein; Dorothea Collins; Gregory Burke; Mary Frances Cotch; Barbara Klein; Mehran M Sadeghi; Jersey Chen
Journal:  Ophthalmology       Date:  2011-12-23       Impact factor: 12.079

4.  Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.

Authors:  Arseniy P Yashkin; Paul Hahn; Frank A Sloan
Journal:  Ophthalmology       Date:  2016-08-11       Impact factor: 12.079

5.  Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration.

Authors:  Lauren A Dalvin; Matthew R Starr; Jackson E AbouChehade; Gena M Damento; Maria Garcia; Saumya M Shah; David O Hodge; Irene Meissner; Sophie J Bakri; Raymond Iezzi
Journal:  JAMA Ophthalmol       Date:  2019-05-01       Impact factor: 7.389

6.  Evaluation of plasma vascular endothelial growth factor levels after intravitreal injection of ranibizumab and aflibercept for exudative age-related macular degeneration.

Authors:  Izumi Yoshida; Tomoaki Shiba; Hikari Taniguchi; Mao Takahashi; Takeyoshi Murano; Nobuyuki Hiruta; Yuichi Hori; Hdieaki Bujo; Takatoshi Maeno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-17       Impact factor: 3.117

7.  [Analysis of cardiovascular diseases after the upload phase with intravitreal ranibizumab and bevacizumab in patients with exudative age-related macular degeneration].

Authors:  C Fischer; K Schäfer; T Dschietzig; H Hoerauf
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

8.  Blood coagulation parameters after intravitreal injection of aflibercept in patients with neovascular age-related macular degeneration.

Authors:  Hasan Altinkaynak; Meltem Ece Kars; Piraye Zeynep Kurkcuoglu; Nagihan Ugurlu
Journal:  Int Ophthalmol       Date:  2017-10-12       Impact factor: 2.031

9.  Gender differences and the trend in the acute myocardial infarction: a 10-year nationwide population-based analysis.

Authors:  Hung-Yu Yang; Jen-Hung Huang; Chien-Yeh Hsu; Yi-Jen Chen
Journal:  ScientificWorldJournal       Date:  2012-09-10

10.  Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.

Authors:  Der-Chong Tsai; Shih-Jen Chen; Chin-Chou Huang; Pesus Chou; Chia-Min Chung; Po-Hsun Huang; Shing-Jong Lin; Jaw-Wen Chen; Tseng-Ji Chen; Hsin-Bang Leu; Wan-Leong Chan
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.